St Jude gains Japanese approval for spinal cord stimulation system

1 Oct 2010

Your browser does not support inline frames or is currently configured not to display inline frames.
St Jude Medical, Inc. (NYSE:STJ) has received Japanese
approval to market its Eon Mini spinal cord stimulation (SCS) system in
the country.

The neurostimulator is used to manage chronic pain of the trunk or
limbs and pain from failed back surgery by delivering mild
electrical pulses to the spinal cord, which interrupt or mask the
pain signals’ transmission to the brain.

The rechargeable neurostimulator weighs just 29 grams and has a 10mm
profile, giving greater implant depth and patient comfort than other
devices. Its small size also allows for a smaller incision, which
gives physicians increased flexibility in selecting the implant
location.

“With the Eon Mini neurostimulator we are now able to offer
physicians a best-in-class product to help them meet the needs of
patients who require a smaller, long-lasting rechargeable system in
order to manage their chronic pain,” said William Phillips,
president of St Jude Medical Japan. “The launch of the Eon Mini
spinal cord system — the first rechargeable technology in Japan — is
an excellent addition to our growing portfolio of neurostimulation
products available from St Jude Medical Japan.”